Description?: ArQule, Inc. (Nasdaq: ARQL), a recognized leader in small-molecule chemistry, is advancing a portfolio of novel drug candidates for the treatment of cancer and inflammation.
arqule, OCE, Optimal Chemical Entities, ACT, Activated checkpoint therapy, Lead Generation, Lead Optimization, Drug Discovery, Combinatorial Chemistry, oncology, Target validation, inflammation, Drug Development, Cheminformatics, Steve Hill, Andrew Uprichard, Pre-clinical or preclinical, High-throughput, Cyclis, high-throughput automated chemistry, rapid parallel chemistry, ...
Description?: Exelixis is an integrated drug discovery and development company. Our primary mission is to improve patient care by developing proprietary human therapeutics that target the complex molecular causes of disease.